Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2011 (2011), Article ID 645643, 7 pages
http://dx.doi.org/10.1155/2011/645643
Research Article

Lower Frequency of CD62Lhigh and Higher Frequency of TNFR2+ Tregs Are Associated with Inflammatory Conditions in Type 1 Diabetic Patients

1Department of Immunology, Medical University of Gdańsk, Dębinki 1, 80-210 Gdańsk, Poland
2Diabetological Department, Clinic of Pediatrics, Hematology, Oncology and Endocrinology, Medical University of Gdańsk, 80-210 Gdańsk, Poland

Received 20 September 2010; Revised 8 December 2010; Accepted 21 January 2011

Academic Editor: Alex Kleinjan

Copyright © 2011 Monika Ryba et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Atkinson and E. H. Leiter, “The NOD mouse model of type 1 diabetes: as good as it gets?” Nature Medicine, vol. 5, no. 6, pp. 601–604, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Brusko and M. Atkinson, “Treg in type 1 diabetes,” Cell Biochemistry and Biophysics, vol. 48, no. 2-3, pp. 165–175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Michalek, Z. Vrabelova, Z. Hrotekova et al., “Immune regulatory T cells in siblings of children suffering from type 1 diabetes mellitus,” Scandinavian Journal of Immunology, vol. 64, no. 5, pp. 531–535, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Falcone, F. Facciotti, N. Ghidoli et al., “Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice,” Journal of Immunology, vol. 172, no. 10, pp. 5908–5916, 2004. View at Google Scholar · View at Scopus
  5. A. Kukreja, G. Cost, J. Marker et al., “Multiple immuno-regulatory defects in type-1 diabetes,” Journal of Clinical Investigation, vol. 109, no. 1, pp. 131–140, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Jonuleit, E. Schmitt, M. Stassen, A. Tuettenberg, J. Knop, and A. H. Enk, “Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood,” Journal of Experimental Medicine, vol. 193, no. 11, pp. 1285–1294, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Baecher-Allan, J. A. Brown, G. J. Freeman, and D. A. Hafler, “CD4+CD25+ regulatory cells in human peripheral blood,” Journal of Immunology, vol. 167, no. 3, pp. 1245–1253, 2001. View at Google Scholar · View at Scopus
  8. S. Hori, T. Nomura, and S. Sakaguchi, “Control of regulatory T cell development by the transcription factor Foxp3,” Science, vol. 299, no. 5609, pp. 1057–1061, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. K. J. Maloy and F. Powrie, “Regulatory T cells in the control of immune pathology,” Nature Immunology, vol. 2, no. 9, pp. 816–822, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Huehn, K. Siegmund, J. C. U. Lehmann et al., “Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells,” Journal of Experimental Medicine, vol. 199, no. 3, pp. 303–313, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. J. R. MacKinnon, R. M. Knott, and J. V. Forrester, “Altered L-selectin expression in lymphocytes and increased adhesion to endothelium in patients with diabetic retinopathy,” British Journal of Ophthalmology, vol. 88, no. 9, pp. 1137–1141, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. S. M. Pop, C. P. Wong, Q. He et al., “The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice,” Diabetes, vol. 56, no. 5, pp. 1395–1402, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Szanya, J. Ermann, C. Taylor, C. Holness, and C. G. Fathman, “The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7,” Journal of Immunology, vol. 169, no. 5, pp. 2461–2465, 2002. View at Google Scholar · View at Scopus
  14. K. V. Tarbell, L. Petit, X. Zuo et al., “Dendritic cell-expanded, islet-specific CD4+CD25+CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice,” Journal of Experimental Medicine, vol. 204, no. 1, pp. 191–201, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Lepault and M. C. Gagnerault, “Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice,” Journal of Immunology, vol. 164, no. 1, pp. 240–247, 2000. View at Google Scholar · View at Scopus
  16. F. Annunziato, L. Cosmi, F. Liotta et al., “Phenotype, localization, and mechanism of suppression of CD4+CD25+ human thymocytes,” Journal of Experimental Medicine, vol. 196, no. 3, pp. 379–387, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Valencia, G. Stephens, R. Goldbach-Mansky, M. Wilson, E. M. Shevach, and P. E. Lipsky, “TNF downmodulates the function of human CD4+CD25hi T-regulatory cells,” Blood, vol. 108, no. 1, pp. 253–261, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Gustavsson, E. Agardh, B. Bengtsson, and C. D. Agardh, “TNF-α is an independent serum marker for proliferative retinopathy in type 1 diabetic patients,” Journal of Diabetes and Its Complications, vol. 22, no. 5, pp. 309–316, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Zorena, J. Myśliwska, M. Myśliwiec et al., “Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children,” Mediators of Inflammation, vol. 2007, Article ID 92196, 5 pages, 2007. View at Publisher · View at Google Scholar
  20. American Diabetes Association, “Diagnosis and classification of diabetes,” Diabetes Care, vol. 26, pp. 3160–3167, 2003. View at Google Scholar
  21. W. Łuczyński, A. Stasiak-Barmuta, R. Urban, M. Urban, B. Florys, and M. Hryszko, “Lower percentages of T regulatory cells in children with type 1 diabetes—preliminary report,” Pediatric Endocrinology, Diabetes and Metabolism, vol. 15, no. 1, pp. 34–38, 2009. View at Google Scholar
  22. M. B. Gomes, L. J. Piccirillo, V. G. Nogueira, and H. J. Matos, “Acute-phase proteins among patients with type 1 diabetes,” Diabetes and Metabolism, vol. 29, no. 4, pp. 405–411, 2003. View at Google Scholar · View at Scopus
  23. A. J. Wu, H. Hua, S. H. Munson, and H. O. McDevitt, “Tumor necrosis factor-α regulation of CD4+CD25+ T cell levels in NOD mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 19, pp. 12287–12292, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. M. T. Schram, N. Chaturvedi, C. G. Schalkwijk, J. H. Fuller, and C. D. A. Stehouwer, “Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes—The EURODIAB Prospective Complications Study,” Diabetologia, vol. 48, no. 2, pp. 370–378, 2005. View at Publisher · View at Google Scholar
  25. E. Renard, “Monitoring glycemic control: the importance of self-monitoring of blood glucose,” American Journal of Medicine, vol. 118, no. 9, supplement, pp. 12S–19S, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Myśliwiec, A. Balcerska, K. Zorena et al., “Selected immunologic and biochemical risk factors of the retinopathy and nephropathy development in children with diabetes mellitus type 1,” Pediatric Endocrinology, Diabetes and Metabolism, vol. 12, no. 4, pp. 269–273, 2006. View at Google Scholar
  27. M. Myśliwiec, K. Zorena, A. Balcerska, and J. Myśliwska, “Does tumor necrosis factor-α preceed occurrence of microalbuminuria in type 1 diabetes mellitus children?” Journal of the Polish Diabetological Association, vol. 6, no. 3, pp. 131–136, 2006. View at Google Scholar